Meet with a healthcare provider in minutes and receive the best care for the best value.
Muscle spasticity
Cannabis for Muscle spasticity
Muscle spasticity is a condition characterized by involuntary muscle stiffness or spasms caused by disrupted communication between the brain, spinal cord, and muscles. It is often associated with neurological conditions such as multiple sclerosis (MS), cerebral palsy, spinal cord injuries (SCIs), and strokes or other traumatic brain injuries (TBIs). This debilitating symptom can impair mobility, cause significant pain, and reduce overall quality of life. Spasticity affects over 12 million people worldwide.
While conventional treatments such as physical therapy, muscle relaxants, and antispasmodic medications are often prescribed, medical cannabis is emerging as a promising therapy for managing muscle spasticity, particularly in cases where other treatments have proven inadequate.
Spasticity causes
Muscle spasticity occurs due to damage or dysfunction in the central nervous system (CNS), which interferes with the brain’s ability to regulate muscle movement. Common causes include:
Multiple sclerosis (MS): An autoimmune disease that damages nerve fibers in the brain and spinal cord, leading to muscle stiffness and spasms
Cerebral palsy: A group of disorders affecting movement and muscle tone caused by brain damage during early development
Spinal cord injury (SCI): Trauma to the spinal cord disrupts signals between the brain and muscles, resulting in spasticity
Stroke: Reduced blood flow to the brain can cause muscle tightness and involuntary contractions
Traumatic brain injury (TBI): Injury to the brain can impair motor control and result in muscle stiffness
Neurodegenerative disorders: Conditions such as amyotrophic lateral sclerosis (ALS, aka Lou Gehrig’s disease) can cause progressive muscle spasticity
Spasticity symptoms & health effects
Muscle spasticity presents with a variety of symptoms that can range from mild to severe, depending on the underlying condition:
Muscle tightness and stiffness
Sudden, involuntary muscle spasms
Painful cramps or contractions
Reduced range of motion in joints
Difficulty with walking, sitting, or other movements
Muscle weakness or fatigue
Over time, chronic spasticity can cause significant health effects, including:
Joint deformities and contractures
Pain and discomfort
Loss of independence in daily activities
Increased risk of pressure sores due to immobility
Spasticity diagnosis
Diagnosing muscle spasticity involves evaluating a patient’s medical history, symptoms, and physical functioning. Key diagnostic steps include:
Clinical evaluation: Assessing muscle stiffness, reflexes, and range of motion
Neurological examination: Identifying underlying neurological conditions through nerve and brain assessments
Imaging tests: MRI or CT scans to identify brain or spinal cord damage
Functional assessments: Evaluating the impact of spasticity on mobility and daily activities
Spasticity prognosis
The prognosis for muscle spasticity depends on the underlying cause, severity of the condition, and treatment effectiveness. While some individuals may achieve significant improvement with early diagnosis and treatment, others may experience chronic spasticity requiring long-term management. Comprehensive care involving multiple therapies can help maintain mobility, reduce symptoms, and improve quality of life.
Spasticity treatments
Treatments for muscle spasticity tend to center around medication and physical therapy. However, in some instances, more invasive treatments and surgeries may be required.
First-line treatments
Conventional treatments for muscle spasticity aim to reduce stiffness, improve mobility, and alleviate pain. These include:
Physical therapy: Exercises and stretches to maintain muscle flexibility and strength
Oral medications:
Muscle relaxants, such as baclofen or tizanidine
Antispasmodic drugs like diazepam (benzodiazepine)
Botulinum toxin (Botox): Injections to block nerve signals and temporarily relax spastic muscles.
Other treatments
For patients who do not respond to first-line therapies, additional treatments may include:
Intrathecal baclofen therapy (ITB): Implanting a pump to deliver baclofen (a muscle relaxant medication) directly into the spinal cord
Nerve blocks: Injections to temporarily reduce muscle activity in specific areas
Orthotic devices: Braces or splints to improve mobility and prevent joint deformities
Surgical interventions: Procedures to release tight muscles or reduce nerve activity
Adjunctive therapy & alternative treatments
Adjunctive therapies can complement conventional treatments to enhance symptom relief:
Complementary approaches: Yoga, acupuncture, and massage therapy may help reduce muscle stiffness and improve relaxation
Behavioral therapy: Techniques to address pain, anxiety, and stress that may exacerbate symptoms
Cannabis for muscle spasticity
Medical cannabis is gaining recognition as an effective alternative or adjunct therapy for muscle spasticity, particularly for those who have not responded to conventional treatments. The cannabinoids found in cannabis, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), interact with the body’s endocannabinoid system (ECS) to regulate muscle tone, reduce inflammation, and alleviate pain.
Cannabis and multiple sclerosis (MS)
Multiple sclerosis is one of the most well-researched conditions for which medical cannabis has demonstrated significant therapeutic potential. MS-related spasticity affects approximately 60-80% of individuals with the disease, often causing severe pain and functional impairment. Research shows that medical cannabis can:
Reduce spasticity: THC and CBD have been shown to decrease muscle tightness and spasms in patients with MS
Improve sleep and mobility: By alleviating spasms and pain, medical cannabis can enhance overall quality of life
In clinical studies, cannabis-based medications such as nabiximols (Sativex), a THC:CBD oromucosal spray, have been approved in various countries for treating MS-related spasticity. Nabiximols have shown efficacy in reducing muscle stiffness and improving patient-reported outcomes.
Cannabis for other causes of muscle spasticity
Beyond MS, medical cannabis shows promise in managing spasticity caused by other neurological conditions:
Cerebral palsy: Studies suggest that cannabis can help reduce muscle rigidity, improve mobility, and alleviate pain in individuals with cerebral palsy
Spinal cord injury (SCI): Cannabinoids can regulate overactive muscle signaling, reducing spasms and improving comfort in SCI patients
Stroke-related spasticity: Preliminary evidence indicates that medical cannabis may reduce spasticity and associated pain in post-stroke patients
ALS (amyotrophic lateral sclerosis): Cannabis may help alleviate spasticity, cramps, and pain associated with ALS, improving patient comfort and sleep quality
Mechanisms of action
Cannabinoids exert their effects on spasticity primarily through the endocannabinoid system (ECS), which plays a role in regulating motor control, pain perception, and inflammation. Key mechanisms include:
CB1 receptors: Found in the brain and spinal cord, activation of CB1 receptors by THC reduces excessive nerve signaling, leading to muscle relaxation
CB2 receptors: Found in immune cells, activation of CB2 receptors reduces inflammation, which can contribute to spasticity
CBD’s modulatory effects: CBD does not directly bind to cannabinoid receptors but influences ECS activity and other pathways, such as serotonin and vanilloid receptors, to reduce anxiety, muscle spasms, and nerve pain
Additional information for patients
When considering medical cannabis for muscle spasticity, patients and healthcare providers should take into account the following factors:
THC vs. CBD ratios: Products with balanced THC:CBD ratios, such as nabiximols (Sativex), are often preferred for spasticity management
Delivery methods:
Oromucosal sprays: Fast-acting and allow for precise dosing
Oils and tinctures: Provide longer-lasting effects
Vaporized cannabis: Offers rapid relief, but requires caution for lung health
Dosing and titration: Start with low doses and gradually increase to find the optimal balance between symptom relief and side effects
Muscle spasticity FAQs
How does medical cannabis help with muscle spasticity?
Cannabinoids like THC and CBD interact with the endocannabinoid system to reduce excessive muscle activity, alleviate pain, and improve mobility.
Is medical cannabis safe for long-term use?
Medical cannabis is generally well-tolerated, but side effects such as drowsiness, dizziness, and dry mouth may occur. Long-term use should be monitored by a healthcare provider.
Can medical cannabis replace conventional treatments for spasticity?
Medical cannabis can be used as an adjunct therapy alongside conventional treatments, particularly for patients who have not achieved relief with other options. There is no evidence that medical cannabis can replace conventional treatments. However, it could reduce the need for opioid-based painkillers and sedatives.
Are there any cannabis-based medications for spasticity?
Yes. Nabiximols (Sativex) is a cannabis-based medication for MS-related spasticity that has been approved in several countries.
Is Sativex (nabiximols) available in the U.S.?
Although nabiximols (Sativex) has been approved for the treatment of spasticity and pain associated with MS in other countries, this is not the case in the U.S. However, this may change in the future.
What is the best delivery method or administration route of medical cannabis for spasticity?
Oromucosal sprays, oils, and tinctures are commonly recommended for spasticity due to their precise dosing and effectiveness.
Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination: https://www.mdpi.com/2227-9059/10/3/539
Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation: https://pubmed.ncbi.nlm.nih.gov/29055461/